ReNeu

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

Mirdametinib (PD-0325901) oral capsule or dispersible tabletOngoingActive not recruitingPhase 2Open NCT03962543 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…